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Abstract
Background: Acceptance and Commitment Therapy (ACT), as a type of behavioral therapy, attempts to respond to
changes in people’s performance and their relationship to events. ACT can affect sleep quality by providing
techniques to enhance the flexibility of patients’ thoughts, yet maintaining mindfullness. Therefore, for the first time,
a systematic review on the effects of ACT on sleep quality has been conducted.
Methods: This systematic review was performed to determine the effect of ACT on insomnia and sleep quality. To
collect articles, the PubMed, Web of Science (WOS), Cochrane library, Embase, Scopus, Science Direct, ProQuest,
Mag Iran, Irandoc, and Google Scholar databases were searched, without a lower time-limit, and until April 2020.
Results: Related articles were derived from 9 research repositories, with no lower time-limit and until April 2020.
After assessing 1409 collected studies, 278 repetitive studies were excluded. Moreover, following the primary and
secondary evaluations of the remaining articles, 1112 other studies were removed, and finally a total of 19
intervention studies were included in the systematic review process. Within the remaining articles, a sample of 1577
people had been assessed for insomnia and sleep quality.
Conclusion: The results of this study indicate that ACT has a significant effect on primary and comorbid insomnia
and sleep quality, and therefore, it can be used as an appropriate treatment method to control and improve
insomnia.
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Background
Sleep is known as a complex, active and repetitive
physiological and behavioral phenomenon. During sleep,
a person’s perceptual detachment from the environment
and a lack of response to it are observed [1]. Sleep can
be measured in terms of quality and duration, and these
two parameters have little overlap. In general, sleep
quality is a subjective index that measures how a person
experiences sleep, while sleep duration is simply the
measurement of the length of time a person sleeps.
Disruption to any of these parameters leads to insuffi-
cient sleep and increases drowsiness during the day [2].
Insomnia is a 24-h disorder that occurs throughout
the day and night [3]. It is known as the most common
type of sleep disorder and can be instigated by primary
causes or can be comorbid (due to another illness) [4].
There are different reasons for insomnia; it can also be
developed occasionally, repeatedly and continuously.
According to the International Classification of Sleep
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Disorders-Third Edition (ICSD3), insomnia is a condi-
tion in which there are sleep initiation or maintenance
problems, adequate opportunities and cicumstances to
sleep, and daytime consequences. If a person encounters
these conditions 3 or more times during a week and the
condition persists for 3 months, s/he will be diagnosed
with insomnia [5]. The exact type of insomnia can be
detected by polysomnography [6]. During insomnia, the
cerebral cortex is more active, which increases hyper
arousal in the individual [3]. Insomnia is a serious
mental disorder and affects the quality of life, increasing
fatigue during the day and the occurrence of various
cardiovascular diseases and diabetes [7, 8]. Despite the
high prevalence, there is still little known about this
disorder [7].
Cognitive Behavioral Therapy is the first-line treat-
ment for chronic insomnia [9]; This behavioral therapy
is designed based on the operationally defined learning
theory and its adaptation to empirical models. Behav-
ioral therapy has three types: traditional, cognitive
behavioral, and the third-wave thereapies [10]. The
cognitive-behavioral therapy was introduced by using
traditional behavioral therapy principles and special
emphasis on cognitive factors and processes [11].
CBT-I is a multi-component approach, in which com-
ponents such as psychology education in sleep health,
behavioural interventions such as stimulus control and
cognitive techniques are adopted [12]. CBT-I affects the
factors influencing insomnia preservation. These factors
include dysregulation of sleep drive, sleep-interfering be-
haviours, and cognitions [13].
CBT-I in the short term has the same effect as drug
therapy on insomnia. Since the drug treatments pose
long-term side effects in people with insomnia, the
desire to treat with CBT has increased [14, 15]. A
meta-analysis study by Geiger-Brown et al. (2015)
found that sleep quality improves after the CBT-I
treatment. This improvement was more pronounced 3
to 18 months after the treatment [16]. According to
another meta-analysis conducted by van Straten et al.
(2018), the effect of CBT treatment on insomnia in-
tensity indicators, sleep quality, sleep efficiency and
delayed onset of sleep was statistically significant,
which can be concluded that this method is effective
in treating insomnia [17].
Acceptance and commitment therapy (ACT) is known
as one of the third-wave behavioral therapies. The third
wave approaches, in addition to emphasizing the form of
psychological phenomena, also have a special emphasis
on the functions and contents. Third-wave interventions
use concepts such as mindfulness, acceptance, and
cognitive diffusion to alter people’s performance and
relationship to events. Whereas in previous generations
of behavioral therapies, only the direct change in events
was considered [10]. ACT is known as a psychological
intervention based on modern behavioral psychology in
which individuals change their relationships with
physical thoughts and feelings [18, 19]. In fact, ACT is
based on a comprehensive scientific philosophy called
functional contextualism, in which functional verbal and
behavioral hypotheses are reflected in ACT in several
ways [20]. ACT includes 6 treatment processes: Accept-
ance, Diffusion, Contact with the percent movement,
Self as context, Values, and Committed action [19].
Moreover, instead of making changes to the form of
experience, therapists amend its functions (Fig. 1) [20].
Several studies have reported the effect of ACT on
various mental disorders, however, only a few research
works have focused on the effect of ACT on insomnia.
For instance, studies have examined the effect of mind-
fulness as one of the third wave interventions, as well
as one aspect of ACT that has been shown to improve
mindfulness for sleep quality improvement [21]. A case
example research work by Lunde & Norhus (2009), on
a 70-year-old person, found that ACT improves sleep
quality [22]. Since sleep disorder is known to be one of
the most common disorders in the world, and if left
untreated, it will add further pressure on society, its
treatment is vital. Due to the side effects of long-term
use of drug therapies, alternative psychological therap-
ies can be used [23]. This systematic review examines
the effects of acceptance and commitment therapy on
(1) primary insomnia disorder, (2) secondary insomnia
disorder, and (3) sleep quality and other sleep
parameters.
Methods
Studies’ eligibility criteria
In this work, in order to follow a structured approach,
the 4-step PRISMA meta-analysis guidelines were
followed [24]. Criteria for entering the study included,
(1) intervention studies, (2) studies in which the inter-
vention was based on acceptance and commitment ther-
apy, (3) studies in which the full text was available, and
(4) studies that were assessed as high and medium
quality (i.e. studies with quality score of 18 or above).
The exclusion criteria are also listed in Table 1.
Search strategy and method
This systematic review was performed to determine the
effect of ACT on insomnia and sleep quality. To collect
articles, the PubMed, Web of Science (WoS), Cochrane
library, Embase, Scopus, Science Direct, ProQuest, Mag
Iran, Irandoc, and Google Scholar databases were
searched, without a lower time-limit, and until April
2020. The keywords that were used were Acceptance
commitment therapy, Acceptance based, accept*
commit*, insomnia, sleep wake disorder, sleep, “sleep
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quality”, sleep problem, sleep parameters, objective sleep,
sleep maintenance, and the process followed the search
approach required for each database; For instance, Table
1. presents the search strategy used for the PubMed
database, and lists the inclusion and exclusion criteria.
In order to examine the gray literature (dissertations,
conference proceedings), the assessment of other related
sites was also conducted. However, due to the lack of
proper referencing mechanism, the very low quality of
the results presentation in some of such articles, and
also due to resources limitations, the authors removed
the gray literature from this work.
In order to maximize the comprehensiveness of the
search, the lists of references used in all related articles
found in the above search were manually reviewed. Ini-
tially, articles that were repeated in various databases
were removed from the selection. Then, a list of the ti-
tles of all the remaining articles was prepared, to evalu-
ate the articles in a structured way. At the first stage, i.e.
screening, the title and abstract of the articles were care-
fully examined, and considering the inclusion and exclu-
sion criteria, unrelated articles were removed. In the
second stage, i.e. eligibility assessment, the full texts of
the possible related articles remaining from the screen-
ing stage were examined, based on the inclusion and ex-
clusion criteria, and similarly the ineligible articles were
excluded. To prevent subjectivity, all stages of resource
review and data extraction were conducted by two re-
viewers independently. If an article was not included, the
reason for the exclusion was mentioned. In cases where
there was a disagreement between the two reviewers, a
third person reviewed the article.
Fig. 1 Types of Behavioral Therapy Methods and the basis for Acceptance and Commitement Therapy
Table 1 A) Inclusion criteria, B) Exclusion criteria and C) Search Strategy in PubMed
A)
1) Intervention study
2) The studies in which the intervention was performed were based on
acceptance and commitment therapy
3) Studies with full text
4) High quality studies and scores above 18
B)
1) Observational study
2) Case report
3) Case series
4) Studies whose full text was not available
5) Studies with a quality score of less than 20
6) Studies whose intervention is another method
of behavioral therapy
7) Studies with distorted data
C)
(acceptance commitment therapy[mesh] OR Acceptance based[tiab] OR accept* commit*[tiab]) AND (insomnia[tiab] OR sleep wake disorder[mesh]
OR sleep[tiab] OR “sleep quality”[tiab] OR sleep problem[tiab] OR sleep parameters[text word] OR objective sleep[text word] OR sleep
maintenance[text word])
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Quality assessment
In order to evaluate the quality of articles (i.e. meth-
odological validity and results), a checklist appropriate
to the type of study was used. CONSORT checklists
are commonly used in interventional studies to
critique and evaluate quality of articles [25]. The
CONSORT checklist consists of six scales/general
sections including: title, abstract, introduction,
methods, results, and discussion. Some of these scales
have subscales, resulting in a total of 37 fields. In
fact, these 37 fields represent different methodological
aspects of a piece of research, such as title, problem
statement, study objectives, study type, statistical
population, sampling method, definition of variables
and procedures, data collection methods, statistical
analysis methods and findings. The maximum score
that can be obtained from CONSORT is 37; Consid-
ering the score of 18 as the cut-off point [26], articles
with scores of 18 or above were considered as
medium or high-quality articles. Articles with a score
below 18 were considered as low quality research
works with respect to their methodological frame-
work. In this study, low quality articles were excluded
from the final selection.
Results
Article selection
A total of 1409 articles were collected from various data-
bases. After removing 288 duplicate articles, the initial
evaluation stage was conducted in accordance to the in-
clusion and exclusion criteria. At this stage of the sys-
tematic review process, by reviewing the title and
abstract of 1131 articles, 160 articles were approved and
entered the secondary evaluation phase. After reviewing
the full text of the articles based on the inclusion and
exclusion criteria, and also assessing the quality of the
articles using the CONSORT checklist [26], 19 articles
entered this systematic review study; Fig. 2.
Articles quality
After the implementation of the systematic review
process, 19 intervention studies were approved and eval-
uated. These studies are described in Table 2. In general,
Randomised Control Trial (RCT) studies were of better
quality, which could be due to the high risk of publica-
tion bias among them. The methodological quality of
the articles included in this study was determined using
the CONSORT checlist, which offered a score ranging
from 18 to 28, with an overall average score of circa 22.
In 8 studies, the included data were redacted [26]. In a
small number of articles, using linear mixed effect
models, the parameters were generated by taking into
account the missing data, indicating intention-to-treat
analyses.
Participants
The sample size in the articles included in this study
ranged from 4 to 232. A total of 1577 people were
assessed for primary and secondary insomnia and sleep
quality, of which 1058 were in the ACT intervention
group. In the comparison or control groups, 32 people
were treated with CBT (cognitive behavioral therapy), 80
people were treated with present-centered therapy, 20
people were treated with Tinnitus Retraining Therapy,
and 78 people were treated with exercise therapy. The
type of intervention was unclear for 129 patients, and no
treatment was performed on 180 people. A total of 11
out of the 19 studies had a control or comparison group.
All participants in the studies were all adults i.e. over 18
years old. Most of the participants were women, which
potentially shows that women suffer from insomnia
more than men.
In a research conducted by Hesser et al. [28], in
Sweden, there were 35 participants in the intervention
group and 32 participants in the comparator group, with
the CBT measurements conducted using an internet-
based self-administered questionnaire. In this work, the
mean score of insomnia was reduced equally by CBT
and ACT. However, follow-up studies after a year
showed that the severity of insomnia in the ACT treat-
ment method was higher than the initial state and the
sleep intensity in CBT was almost back to normal. The
control group also showed a slight decrease in the sever-
ity of insomnia during the 2 months of treatment.
Nonetheless, in patients who do not respond well to
CBT-I treatment, ACT is recognised as an alternative
treatment [13].
In most studies, the effect of ACT was measured on
various diseases. In other words, most studies have
examined the effect of ACT on comorbid insomnia.
Considering Tables 2, 5 studies have assessed the effect
of ACT on people with chronic pain [30, 33, 37, 41, 43].
One research work also studied the Fibromyalgia condi-
tion which has symptoms such as widespread pain and
fatigue [27]. In another work, patients with Osteoarth-
ritis who also suffered from chronic pain were examined
[31]. The effects of ACT on various aspects of chronic
fatigue, especially sleep, were investigated in three pieces
of research [32, 34, 38]. Three studies also examined
patients with cancer [35, 39, 40]. Two articles studies
patients with Tinnitus [28, 29] and another work exam-
ined people with mental disorders [36]. Only 3 research
works have examined the effect of ACT interventions on
primary insomnia [21, 42, 44].
Different criteria were used to measure insomnia and
sleep quality in the selected research works. Some of
these works have used several methods to measure sleep
patterns in their samples. Overall, in 11 studies, insom-
nia was measured by the Insomnia Severity Index (ISI)
Salari et al. BMC Neurology          (2020) 20:300 Page 4 of 18
[28–30, 32, 34, 37, 38, 40–43]. In 4 studies, sleep quality
was assessed using the PSQI questionnaire [21, 27, 33,
44]. In another work, parts of the ICOAP questionnaire
examined sleep and well-being in the study sample [31].
Another piece of research utilised a GHQ questionnaire
to measure anxiety and insomnia [36]. Sleep quality was
measured in an article with the BNSQ questionnaire
[42]. In 2 works, using 4 items from the PROMIS ques-
tionnaire, sleep disturbance was evaluated [35, 39]. Fur-
thermore, in a study, sleep related impairment was
Fig. 2 PRISMA flow diagram demonstrating the stages for inclusion of studies in the systematic review
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measured by the PROMIS questionnaire [39]. The ESS
questionnaire, which measures daytime sleepiness, was
used in 1 research work, and the DBAS questionnaire,
was used in 2 studies [42, 44]. The sleep diary criteria,
which includes sleep onset latency (SOL), wake time
after sleep onset (WASO) and total sleep time (TST),
were examined in 2 articles [34, 37]. Sleep efficacy (SE)
was also evaluated in another work [37]; (Table 2).
Investigating the interventions
In the selected studies, the intervention was performed
in different ways. In 4 studies, the protocol therapy was
performed in person, and individually on the study
sample [21, 29, 41, 44]. In 2 other studies, all sessions
were performed in groups [31, 43]. In one of these
research works, acceptance and commitment therapy
based stress management (ACT-bsm) was utilised [43].
Some other studies used both group and individual
methods to hold meetings [32, 34, 37, 38]. The tele-
phone based ACT method was reported in 2 articles [35,
39]. ACT was performed virtually and in an online plat-
form in 3 other works [27, 28, 42]. In another piece of
research, face-to-face and video conferencing were per-
formed simultaneously with two different groups [33]. In
another research project, face-to-face and virtual video-
based sessions were scheduled, in which the combined
CBT-ACT therapy was performed [40].
The number of treatment sessions reported in the ex-
amined research works also varied. In general, ACT was
presented with different protocols in different projects,
which led to variances in the number of study sessions.
In 6 projects, ACT was presented in 8 sessions [21, 28,
32, 33, 36, 44]. The average number of sessions pre-
sented in the study by Westin et al. (2011) was 8.37. In
this work, a maximum of 10 sessions were planned to
present the content [29]. Four other studies scheduled 7
sessions as part of the project. In the research project
conducted by Zetterqvist et al. (2018), the last session
was performed when people were called in for a follow
up [27, 37, 38, 43]. Some other studies used 6 sessions
of therapy to present their findings in accordance with
the ACT principles [31, 35, 39, 42]. The use of 3 sessions
[40], 10 sessions [30] and 12 treatment sessions was also
observed in the various pieces of research [41]. The
timing of each session was also different. Considering
Table 3, the time for presenting sessions in different
studies was reported from 50min to 7 h per day
(Tables 3, 4).
Different statistical methods and analyzes were con-
ducted to investigate the effect of the interventions.
Nevertheless, considering the results of existing research
works, in general, ACT has a positive effect on the sever-
ity of insomnia (ISI) and reduces its severity. The
research conducted by Craner et al. (2020) showed a
high positive effect of ACT on reducing insomnia, which
was statistically significant, ranging from 13.86 ± 6.89 to
9.39 ± 5.97 after intervention [30]. Other studies have
shown a positive and significant effect of the interven-
tion on the severity of insomnia, with the following value
ranges: 12.2 ± 6.1 to 9.8 ± 6.4 [32], 12 ± 6.07 to 9.51 ±
6.12 [38], 15.2 ± 6.6 to 11.8 ± 7.7 [41] and 12.25 ± 5.92 to
9.03 ± 5.92 [34], 5.71 ± 0.41 to 3.39 ± 0.39 [40], 11.90 ±
4.66 to 9.25 ± 5.17 [29], 14.23 ± 6.00 to 13.25 ± 6.30 after
intervention [43]. In the work of Wiklund et al. (2018), a
decrease in ISI score was observed throughout the study
period (after treatment, 6-month follow-up, and 12-
month follow-up), which was only statistically significant
in the 12-month follow-up [43]. Moreover, another
research work found a positive and significant effect of
ACT intervention on ISI compared to other interven-
tions [29]. In the study of Hesser et al. (2012), no statis-
tical significance was observed in the comparison
between the intervention group and the control group,
before and after intervention [28].
The Pittsburgh Sleep Quality Index (PSQI) was used
in 4 studies; PSQI showed improvement in sleep quality
after intervention in 2 studies, which was statistically
significant [21, 44], yet this was not statistically signifi-
cant in the other two works [27, 33]. Sleep disturbance
was measured in 2 research works using parts of the
PROMIS questionnaire; the findings demonstrated only
a minor change in the score from the questionnaire, and
that it was not statistically significant [35, 39]. Sleep re-
lated impairment were also assessed with the PROMIS
questionnaire, and the score changes were not statisti-
cally significant [39]. Sleeping difficulty was measured by
ESS in 2 studies. In a research work conducted by Päivi
et al. (2019), a comparison of pre-intervention and post-
intervention intervals showed that the mean ESS score
changed slightly, which was not statistically significant,
while a comparison of pre-intervention time interval and
follow-up showed changes that were statistically signifi-
cant [42]. Another study found small changes in the ESS
score that were not statistically significant [40].
In general, changes in DBAS score were reported to be
decreasing, and statistically significant, which meant the
positive effect of the intervention on the dysfunctional
beliefs and attitudes before sleep criteria [42, 44]. The
effect of ACT on sleep and well-being was measured by
ICOAP. The comparison before and after the interven-
tion did not show a significant relationship, while the
comparison of the pre-intervention and the follow-up
periods reported improvement in sleep and well-being,
which is statistically significant [31]. The effect of the
intervention on insomnia and anxiety was measured by
the GHQ instrument, which was statistically significant
[36]. Comparing the average sleep quality score using
the BNSQ instrument at different time intervals showed
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a decrease in the mean score and improvement of the
condition, which was statistically significant [42].
Changes in the SPA instrument, that assesses sleep
problem acceptance, were reported to be statistically sig-
nificant [44].
Sleep diary descriptive criteria were also assessed in a
number of research works. The effect of intervention on
sleep efficacy (SE) was reported to be positive. In fact,
ACT significantly increased SE, and the effect of ACT
on sleep onset latency (SOL) was also reported to be sig-
nificant [37, 40, 44]. Two criteria of total sleep time
(TST) and wake after sleep onset (WASO), were also
measured. The effect of ACT on TST was significant,
yet no significant effect was observed with WASO [37].
In a research conducted by Zakiei & Khazaei (2019), the
effect of ACT on TST and the number of awake sleeps
were measured, which showed a significant improve-
ment in the status of these parameters [44].
Table 3 Investigating Changes in Sleep Intensity Questionnaire
Name intervention
/control
group
Assesment Number
of sessions,
time for
presenting
sessions
pretreatment post
treatment
month
follow up,
mean
square
month
follow up,
mean
square
p- value T test / F effect size
Craner, J. R ACT ISI (Insonia
severity
index)
10,
2–4 h
13.86 (6.89) 9.39
(5.97)
_ _ < 0.001 t = 8.56 d = 0.73
Kallestad, H. ACT ISI 7 12 (6.07) 9.51
(6.12)
_ _ <.001 t = 5.55 d = 0.41
Lang, A. J. ACT ISI 12,
60 min
15.2 (6.6) 11.8 (7.7) _ _ < 0.05 _ d = 0.63
Vethe,
Daniel
ACT ISI – 12.25 (5.92) 9.03
(5.92)
_ _ < 0.001 t = 5.8 d = 0.54
Wells-Di
Gregorio, S.
M.
ACT ISI 3,
90 min
5.71 (0.41) 3.39
(0.39)
_ _ 0.0047 _ d = −1.18
Hugo
Hesser
ACT ISI 8,
120 min
13.23 (5.80) 8.48
(5.43)
12 month,
17.32
(9.85)
_ _ _ _
Control ISI – 13.78 (6.54) 11.22
(6.97)
_ _ 0.1 t < 1.70 d = 0.41
CBT ISI 8,
120 min
14.66 (6.30) 9.93
(6.85)
12 month,
12.03
(8.39)
_ 0.043 t = 2.06 d = 0.52
Westin, V.
Z.
ACT ISI 10 11.90 (4.66) 9.25
(5.17)
6 month,
(9.19
(6.07))
18 month,
8.90 (5.49)
_ _ _
Control ISI – 11.91 (6.60) 11.80
(6.14)
_ _ 0.022 f = 5.67 d = 0.22
TRT ISI – 12.60 (5.70) 13.06
(5.63)
6 month,
11.47
(5.81)
18 month,
12.57
(6.33)
0.043 f = 4.19 d (6 month) = 0.71,
d(18 month) = 0.63
Wiklund, T. ACT ISI 7120 min 14.23 (6.00) 13.25
(6.30)
6 month,
13.24
(6.38)
12 month,
12.22
(6.38)
Post treatment = 0.071,
6 month
follow up = 0.215,
12 month
follow up = 0.009
_ d(Post treatment) = − 0.207,
d(6 month follow
up) = 0.036,
d(12 month follow
up) = − 0.279
Control ISI – 12.76 (7.24) 13.15
(7.46)
6 month,
11.53
(7.29)
12 month,
12.59
(7.13)
Post treatment = 0.234,
6 month
follow up = 0.122,
12 month
follow up = 0.851
_ _
exercise
therapy
ISI 7 13.48 (6.52) 12.14
(6.55)
6 month,
11.64
(7.15)
12 month,
11.19
(6.27)
Post treatment = 0.020,
6 month
follow up = 0.002,
12 month
follow up = 0.001
_ d(Post treatment) = − 0.262,
d(6 month follow
up) = − 0.092,
d(12 month follow
up) = − 0.321
Jacobsen,
H.B
ACT ISI 8150 min 12.2 (6.1) 9.8 (6.4) _ _ < 0.001 5.53 g = 0.38
Zetterqvist,
V.
ACT ISI 7120 min 20.19 (3.78) 10.75
(5.23)
3 month,
11.20
(6.71)
_ g pre-post = 2.02 (0.9,3.14),
g pre-follow
up =1.69 (0.59,2.78)
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Table 4 Statistical data by evaluation criteria
Name intervention
/ control
parameters Number of
sessions,
time for
presenting
sessions
pre
treatment
post
treatment
month
follow up,
mean
square
statistical
analysis
df p F / W
/β(SE)
effect size
/ difference
in change
between
groups
Herbert, M. S ACT /in
person
PSQI 8,
60 min
12.48
(0.49)
11.58
(0.52)
6 month,
11.78
(0.55)
Samples T
test
_ _ _ difference
in change
pre-post,
−0.21
(− 1.63_1.20),
difference in
change
pre-follow
up, − 0.14
(− 1.69_1.42)
ACT/ tele
health
PSQI 8,
60 min
12.16
(0.50)
11.47
(0.61)
6 month,
11.59
(0.67)
_ _ _
Khazaie, H. ACT PSQI 8,
60 min
15.58
(2.31)
5.17
(2.88)
3 month,
3.17
(2.03)
Analysis of
Variance
(ANOVA)
1 0.001 F = 433.77 _
Simister, H. D ACT+TAU PSQI 7 12.67
(3.80)
10.24
(3.60)
10.70
(4.71)
Linear
mixed
effects
modeling
(LMM)
df1 =
2
0.055 _ d(pre-post)
=0.79
(0.26–1.31)
TAU PSQI 7 13.26
(3.80)
13.00
(3.47)
_ _ d(pre-follow
up) = 0.53
(0.2–1.04)
Zakiei, A. ACT PSQI 8,
60 min
16 ± 2.44 5 ± 4 5 ± 4.08 Analysis of
Variance
(ANOVA)
_ < 0.01 _ Cohen’s
d = 1.733
Päivi, L ACT ESS 6 6.85
(4.59)
5.67
(3.81)
5.20
(3.22)
Wald test df = 1 0.001 W = 6.71 Cohen’s d
(pre-post)
= 0.41,
Cohen’s
(pre-follow
up) = 0.69
control ESS – 7.60
(4.28)
7.30
(5.09)
_ df = 2 < 0.001 W = 32.23
Wells-Di
Gregorio, S. M.
ACT ESS 3,
90 min
8.82
(1.11)
7.99
(1.24)
_ linear mixed
models
_ 0.66 _ _
control ESS – 8.09
(1.38)
7.91
(1.46)
_ _ 0.66 _ _
Päivi, L ACT DBAS 6 96.33
(22.81)
86.57
(25.74)
77.47
(29.70)
Wald test df = 1 0.001 W = 10.41 Cohen’s d
(pre-post)
= 0.53
control – 87.93
(20.62)
89.55
(18.85)
_ df = 2 < 0.001 W = 34.86 Cohen’s
(pre-follow
up) = 0.71
Zakiei, A. ACT DBAS 8,
60 min
92.75 ±
5.85
34.25 ±
16.64
3 month,
34.25 ± 14.63
Analysis of
Variance
(ANOVA)
_ < 0.05 _ Cohen’s
d = 1.781
Mosher, C.
E(2019)
ACT PROMIS
(sleep
disturbance)
6,
50 mintes
10.56
(0.71)
10.24
(0.78)
10.04
(0.78)
Linear
mixed
effeect
model
74 0.69 F Value =
0.38
_
education
support
PROMIS – 11.24
(0.71)
10.15
(0.81)
9.85
(0.81)
Mosher, C.
E(2018)
ACT PROMIS
(Sleep-
disturbance)
6,
50–60 min
13.39
(3.24)
12.86
(3.06)
12
(3.27)
Linear
mixed
effeect
model
0.14 β = − 0.49
(0.33)
d(pre-post)
= −0.14
education
support
PROMIS – 11.5
(2.67)
10.96
(2.54)
9.92
(3.23)
d(pre-follow
up) = −0.43
Mosher, C.
E(2018)
ACT PROMIS
(sleep
related
impairment)
6,
50–60 min
23.04
(7.42)
21.61
(5.24)
21.04
(6.55)
Linear
mixed
effeect
model
0.88 β = 0.11
(0.72)
d(pre-post)
= − 0.27
education
support
PROMIS – 18.79
(6.35)
18.79
(4.51)
19.12 (4.97) d(pre-follow
up) = −0.31
Clarke, S. P. ACT ICOAP 6,
90 min
5 (3–7) 4 (3–6) 3 (2–4) Mann-Whitney’s U
test
P (pre-post)
= 0.05
control ICOAP – 6 (4–7) 6 (5–8) 6 (5–7) P (pre-follow
up) = 0.002
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In a study conducted by Clarke et al. (2017), statistical
analysis was performed using the Mann-Whitney’s U
test. It was reported that the passage of time has a
positive impact on the improvement of sleep quality and
well-being after intervention, so that the improvement of
sleep and well-being in the first two months of follow-
Table 4 Statistical data by evaluation criteria (Continued)
Name intervention
/ control
parameters Number of
sessions,
time for
presenting
sessions
pre
treatment
post
treatment
month
follow up,
mean
square
statistical
analysis
df p F / W
/β(SE)
effect size
/ difference
in change
between
groups
Farhang,
Maryam
ACT GHQ 8,
75 min
12.27
(3.35)
7 (2.41) _ multivariate
covariance
analysis
statistical
test
1 0.001 F (pre)
= 92.988
effect (pre)
= 0.830
control GHQ – 12.82
(4.64)
12.73
(3.95)
_ F (post)
= 81.154
effect
(post)
= 0.810
Päivi, L ACT BNSQ 6 21.77
(4.45)
19.91
(5.25)
18.35
(5.42)
Wald test df = 1 0.001 W = 6.71 Cohen’s d
(pre-post)
= 0.42
control BNSQ – 21.65
(4.07)
21.57
(4.5)
_ df = 2 < 0.001 W = 32.23 Cohen’s
(pre-follow
up) = 0.69
Name intervention
/ control
sleep diary Number
of sessions,
time for
presenting
sessions
pre
treatment
post
treatment
follow up statistical
analysis
df p F effect size
Wells-Di
Gregorio, S. M.
ACT SOL (min) 3,
90 min
52.16
(10.43)
30.78
(5.87)
_ linear mixed
models
0.028 −0.86
Zakiei, A. ACT SOL 8,
60 min
1.52
(0.36)
0.96
(0.56)
_ Analysis of
Variance
(ANOVA)
< 0.05 2.806
Zetterqvist, V. ACT SOL (min) 7,
120 min
59
(0:39)
20
(0:10)
25
(0:17)
linear mixed
effects
models
_ _ _ g(pre-post)
= 1.33
(.25, 2.41),
g (pre-follow
up) = 1.08
(−0.15, 2.32)
Wells-Di
Gregorio, S. M.
ACT SE 3,
90 min
0.80
(0.027)
0.9
(0.019)
_ linear mixed
models
_ 0.0062 _ d = 1.08
Zakiei, A. ACT SE 8,
60 min
51.31
(10.6)
79.61
(10.77)
_ Analysis of Variance
(ANOVA)
_ < 0.05 _ d = 2.28
Zetterqvist, V. ACT SE 7,
120 min
68.8
(13.9)
85.8
(6.5)
86.8
(6.7)
linear mixed
effects
models
_ _ _ g(pre-post)
= −1.57
(−2.63,-0.47),
g (pre-follow
up) = −1.58
(−2.90,-0.26)
Zakiei, A. ACT TST 8,
60 min
4:17
(1:26)
6:03
(0:82)
_ Analysis of
Variance
(ANOVA)
_ < 0.05 _ d = 3.37
Zetterqvist, V. ACT TST 7,
120 min
5:46
(1:54)
5:56
(1:17)
6:43
(1:26)
linear mixed
effects
models
_ _ _ g(pre-post)
= −0.10(−1.07,
0.87),
g (pre-follow
up) = − 0.54
(− 1.71, 0.63)
Zakiei, A. ACT number of
awakenings
8,
60 min
1.82
(0.29)
1.32
(1.76)
_ Analysis of
Variance
(ANOVA)
_ < 0.05 _ d = 1.76
Zakiei, A. ACT subjective
quality
8,
60 min
4.07
(1.40)
5.67
(1.83)
_ Analysis of
Variance
(ANOVA)
_ < 0.05 _ d = 3.054
Zetterqvist, V. ACT WASO 7,
120 min
0:46 (0:32) 0:23 (0:33) 0:22 (0:19) linear mixed effects
models
_ _ _ g(pre-post)
= −0.69(−0.31,
1.69),
g (pre-follow
up) = − 0.87
(− 0.33, 2.08)
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up was insignificant, whereas in the 4-month period, this
was statistically significant [31]. In 6 research works,
paired sample t-test was used. In 4 of these studies, the
Cohen d effect was measured, which was statistically sig-
nificant, and the effects in the studies were reported to
be moderate or large [30, 34, 38, 41]. Herbert et al.
(2017) also used a similar statistical analysis method,
however, no statistical significance was observed in their
work [33]. The paired sample t-test was also used to
analyze the results in a research conducted by Jacobsen
et al. (2017). In this test, Hedge g was adopted to meas-
ure the effect, which was calculated as 0.38 and was
statistically significant [32].
Linear effect size model analysis was used in the
study of Hesser et al. (2012), which reported a
statistically insignificant comparison between ACT
intervention and control group. CBT comparison
compared to ACT showed d = 0.52, which was statisti-
cally significant. Interventions were not sustainable
during the follow-up period [28]. In 2 separate stud-
ies, Mosher et al., analysed the data with linear effect
model size, compared the (Group × time) data before
and after intervention; results were not statistically
significant [35, 39]. The linear effect model size was
also used in a research conducted by Westin et al.
(2011). The results of this study showed that compar-
ing ACT versus Control before and after the test is
statistically significant and ACT improves sleep qual-
ity. Moreover, comparing ACT intervention with TRT
in follow-up periods of 6 months and 18 months
showed that ACT is a better treatment than TRT and
its effect is significant throughout the intervention
and follow-up [29]. Wells-Di et al. (2019) followed
the same analysis method, in which a positive and
significant effect of intervention on sleep parameters
was observed [31].
The study of Wiklund et al. (2018) also used linear
effect model size analysis. In this work, the popula-
tion was divided into two groups where there were
completer and non-completer treatments. The calcu-
lated effect size for the group that completed the
treatment was significant in the follow-up period of
18 months and was insignificant in other intervals.
Moreover, after taking into account the total popula-
tion (completer and non-completer), the intervention
was not significant in any of the time periods [43].
Zetterqvist et al. (2018) also used linear effect model
size in their work, according to which ISI and SE
were significant in the lead time period after interven-
tion and in the follow-up interval. TST criteria were
also reported insignificant in the pre and post-
intervention periods, yet statistically significant during
follow-up. The WASO criterion was insignificant in
both ranges [37].
Discussion
This is a systematic review of the evidences and results
reported within 19 studies with a total sample of 1577
patients suffering from primary and comorbid insomnia.
These studies have focused on the effect of ACT inter-
vention on insomnia and sleep quality. The included
studies have been published in the 2012–2020 period, 6
of which were published in 2019 and 2020 [21, 30, 35,
40, 42, 44], and all studies were assessed as medium or
high quality articles. This work is the first systematic re-
view that focuses on the effect of ACT on insomnia.
Despite the many differences in the primary cause of
insomnia, most research works reported a positive and
significant effect of acceptance and commitment therapy
on improving insomnia and sleep quality. Due to the
wide range of tools and criteria used for measuring sleep
quality in the studies, there were also indications of
statistically insignificant effect of ACT on these parame-
ters. Moreover, as some of the comparative studies were
conducted at different time intervals, the statistical
significance or insignificance of the effect were therefore
observed in different time periods.
ACT is based on identifying more efficient behaviour-
ial elements. These elements cause a lasting change in
one’s behavior, which results in the rise of happiness and
fulfillment of personal goals [45]. Studies have shown
that CBTI, as the second generation of behavioral ther-
apies, plays an important role in improving quality and
duration of sleep [46]; accordingly the result from the
work of Edinger et al. have confirmed this through poly-
somnography. Such improvement may persist for up to
24months [47]. Research has also shown that ACT, as
much as CBT, can be as an effective method in treating
physical and mental disorders such as chronic pain, anx-
iety and depression, as well as in treating insomnia [48].
In a work conducted by Castronovo et al. (2018), 258
patients completed the CBT-I treatment. Improvement
in insomnia and sleep diaries were observed in these in-
dividuals. It was also reported that the effect of this
treatment can be stable for up to 10 years [12]. There-
fore, CBT-I can be considered as a suitable treatment
for insomnia. However, Baglioni et al. (2020) - at the
European Academy for Cognitive Behavioral Therapy for
insomnia - reported that patients in Europe do not have
a consistent access to CBT-I and that the use of this
treatment has its drawbacks. Moreover, providing
training on this method for the specialists is a challen-
ging task [13].
ACT is known to treat long-term illnesses. Cancer,
childhood illnesses, pain, heart disease and diabetes are
some of the diseases that have been treated by this ther-
apy. The distinctive feature of ACT is that it can greatly
reduce the side effects of not taking medicine on time,
however, the effectiveness of the long-term use of this
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treatment is still debated by researchers [49]. Other evi-
dences suggest that ACT interventions are also used in a
wide range of psychotic disorders [10]. A research con-
ducted by Orsillo et al. (2005) argued that ACT could be
identified as an effective treatment for Post-traumatic
stress disorder (PTSD) [50]. In the present study, sleep
quality was assessed in patients with chronic pain,
cancer, and tinnitus, before and after intervention.
Several research works have assessed the results of pre-
treatment, up to follow-up interventions, and statistical
significance of the effect of the intervention was reported
in some the works [27, 29, 34, 42, 43]. According to a
2016 cohort study conducted in a population with
chronic pain, ACT improved insomnia, sleep quality,
and sleep efficiency during treatment and follow-up for
9 months after the intervention. This improvement was
statistically significant [51].
ACT is known as one of the third wave treatments
and originates from the cognitive behavioral therapy
(CBT), which increases psychological flexibility. Existing
research works have shown that the effect of ACT in a
3-year follow-up has also been stable [52]. The use of
this behavior therapy method has been observed in a
wide range of diseases, which indicates the flexibility of
this method. This has also increased the desire to use
ACT in recent years [49]. On the other hand, the variety
in the applications of ACT methods e.g. virtual,
telephone-based and face-to-face therapies, also high-
lights the flexibility of this treatment approach. Most of
the treatment strategies used in ACT are derived from
other approaches [53]. ACT pursues a pragmatic and
flexible approach, and reduces inefficient efforts to
control conditions and thoughts, and offers an adaptive
response to diseases [54].
On the whole, ACT is performed with the aim of men-
tal training, increasing motivation, psychological flexibil-
ity and self-efficacy in an individual [32]. Other goals,
such as reducing efforts to control events, identifying
personal goals, and making commitment to take action,
are also followed in this treatment [28, 42]. A study by
Mosher et al. (2019) showed that ACT attempts to de-
velop of mindfulness skills; the authors went on to argue
that it can reduce cancer effects in patients [35]. More-
over, where patients suffer from chronic pain, the goal is
to influence the pain acceptance, increase participation
in life activities, manage thoughts and feelings, change
expectations and goal of a treatment, and express the
possibility of living with pain and improving quality of
life [30, 31, 33].
In most studies, the effect of ACT on improving in-
somnia and sleep quality is observed. The research pro-
jects conducted by Khazaie et al. [21] and Zakiei et al.
[44] examined the effect of ACT on patients with
chronic insomnia. According to the results of these
studies, ACT improves the sleep quality of these pa-
tients. The results of these research works also showed
that the effect of interventions is stable, e.g. the 3-month
follow-up exposed that the quality of sleep is better than
the time before the intervention. The study by Päivi
et al. reported the 6-month stability of the effect of ACT
on sleep quality [42]. The positive effect of ACT on the
parameters of sleep diaries was also reported in the work
of Zakiei et al. [44].
In a study by Jacobsen et al. (2017) in Norway, patients
suffering from chronic fatigue were treated. In this work,
ACT increased the quality of life and reduced fatigue in
the patients, and improved insomnia in the study sample
[32]. This result was also observed in the study of Kalles-
tad et al. (2015). In this piece of research, patients with
chronic fatigue were treated [38]. A study by Vethe et al.
(2018) reported that ACT could improve insomnia in
people with chronic fatigue. Additionally, the stability of
the intervention was also observed in this study. ACT in
the one-year follow-up period also has a positive effect
on physical condition and sleep quality of patients [34].
Therefore, it can be concluded that ACT can be an ef-
fective treatment for the symptoms of chronic fatigue.
Craner et al. (2020) examined 137 patients with
chronic pain. In this research work, ACT was used in
10 sessions with normal treatment methods that
improved insomnia in the patients. Improvement of
pain status, and increase in pain acceptance were also
observed in the patients [30]. Studies by Lang et al.
[41], Simister et al. [27], and Zetterqvist et al. [37] also
reported improvements in insomnia among patients
with chronic pain. On the other hand, studies
conducted by Clarke et al. [31], and Herbert et al. [33]
did not show a positive and significant effect of ACT
on insomnia and sleep quality. Nevertheless, in the
work of Wiklund et al. (2018), a positive and significant
effect of this intervention was observed after 12 months.
In other words, the effect of ACT immediately after
intervention and 6 months after intervention was not
statistically significant [43].
Cancer patients were also considered as a sample in 3
articles. According to a 2019 study by Mosher et al.,
which was performed on patients with advanced lung
cancer, ACT only had small effect on improving the
sleep status of patients and their companions [35]. In an-
other research work by Mosher et al. (2018), the effect
of ACT on the improvement of breast cancer patients
was not observed [39]. However, Wells-Di Gregorio
et al. (2019) reported the positive and significant effect
of ACT in improving insomnia in cancer patients [40].
Research works have demonstrated that ACT can also
be effective in controlling insomnia. Since sleep is not
voluntarily controlled, people may experience feelings of
hopelessness, anxiety, and mood swings. This arousal
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can cause sleeplessness. As a person with insomnia
tries to control his or her thoughts and feelings, his
or her insomnia is exacerbated [46]. Clarke et al.
(2017) applied the techniques to offer their patients
with acceptance using the concepts and exercises of
achieving the will to fight pain, limiting condition
control, focusing on personal experiences, and empha-
sising the notion of ‘living your life’ [31]. Other stud-
ies have used the technique to focus on experience,
self-awareness about positive and negative thoughts
and feelings, as well as the acceptance of attitudes
and unwanted thoughts (Fig. 3) [33, 36, 42].
Cognitive defusion techniques generally demonstrate
that dysfunctional cognition directly plays a role in
negative emotions. They are used to change the shape
and frequency of undesirable behaviors and thoughts
[55, 56]. In fact, these techniques reduce the negative
feelings by changing the background of thoughts [57].
After reviewing various studies, it was found that
teaching how to accept painful events and thoughts
without changing its nature, creating creative frustra-
tion, as well as identifying unwanted thoughts and
learning to describe them are among such cognitive
methods [28, 33, 42, 43].
During the ACT process, contact with the present
resulting moment and life is taught within the right
environment, and the purpose of this work is to con-
nect the person more with his/her surroundings. The
technique itself is very important as a basis, during
which the person talks about his/her experiences
without being dependent on them, the acceptance of
self and loss are strengthened, and in fact, the person
recognises himself/herself as the source of thoughts,
feelings and emotions [58]. In other literature, differ-
ent techniques are used to present the concept of
awareness, such as freedom of thought, expression of
existing contradictions between experience and mind,
training to observe inner experiences, and presence in
the moment [33, 36, 37, 44]. Values have never been
a static goal and are constantly changing, leading to
personal growth. Using the concepts presented in the
ACT protocol, a patient determines own valuable per-
sonal goals and strives to achieve them through com-
mitted and goal-based actions, which improves the
quality of life [10, 56]. In relation to sleep quality,
ACT increases patient’s desire to have a good sleep
experience by making changes in attitudes and
thoughts of the atmosphere, and attracts his/her at-
tention to the negative and defective cycle of these
thoughts with a view to improve sleep quality [21].
Limitations
Some of the initially collected studies were in the
form of dissertations and were excluded from the sys-
tematic review. The lack of access to the full text of
some other articles is another limitation of this work.
Due to the prevalence of the disease, variations in the
samples and analysis techniques, and differences in
outcomes,it was not possible to also conduct a meta-
analysis of the reported results. Except for 2 studies,
no polysomnography was used in other studies, which
could affect the reliability of their findings.
Conclusion
In this systematic review, the effect of ACT on insomnia
and sleep quality was investigated. The results of 3
studies showed that ACT could play an effective role in
improving sleep quality in patients with primary insom-
nia, and the results were statistically significant. Other
research works have demonstrated that ACT is effective
Fig. 3 Therapeutic processes of acce,ptance and commitment therapy
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in reducing the severity of insomnia, and similarly the
results were statistically significant. It can also be argued
that ACT can improve sleep quality. In 2 studies, no sig-
nificant relationship was observed between the treatment
used and sleep quality improvement. Moreover, the
stability of improvement in sleep quality was measured
in different follow-up periods, which can be argued that
the improvements reported in 7 studies were significant,
and no significant relationship was observed in another
4 studies.
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